SemBioSys Genetics Inc., a biotechnology company developing a broad pipeline of protein-based pharmaceuticals and non-pharmaceutical products, announced that its proprietary plant-produced insulin has been demonstrated in animal models to be chemically, structurally and functionally equivalent to U.S. pharma grade human insulin. The results of analytical, in vitro and in vivo assays confirm that insulin produced in safflower, SemBioSys' commercial crop, is indistinguishable from human insulin analytically and physiologically.
Click here to read the whole article.
You are now at the website for online medication without prescription, advantages to herbal medicine, traditional chinese herbal medicine for optimal health, best buy medications, nutritional vitamin supplements.
